Higher Circulating Resistin Levels Linked to Increased Sarcopenia Risk in Older Adults.

Mi Kyung Kwak, Ji Yeon Baek, So Jeong Park, Hee-Won Jung, Eunju Lee, Il-Young Jang, Eunhye Ji, Eun-Gyoung Hong, Yunju Jo, Dongryeol Ryu, Beom-Jun Kim

Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, 18450, South Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, 18450, South Korea. · pubmed

Paper

Abstract

Experimental evidence indicates that resistin, an adipokine, negatively impacts muscle metabolism by hindering myogenesis.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the relationship between circulating resistin levels and sarcopenia risk in older adults, which is relevant to aging and age-related muscle degeneration. However, while it contributes to understanding a factor associated with sarcopenia, it does not address root causes of aging or propose solutions for lifespan extension. Thus, its impact is solid but limited.

Author of this paper? Send a correction.